VEGFA and cholangiocarcinoma: In cervical cancer (CC) models, tetrahydrocurcumin—one of the major metabolites of curcumin in vivo—exhibits potent anti-angiogenic effects by targeting the HIF-1α/VEGF-VEGFR-2 axis [19].